Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Partial clinical hold on Epizyme's new enrollments By: MarketMinute.com Stock News April 24, 2018 at 18:02 PM EDT The Food and Drug Administration issued a partial clinical hold on new enrollments for Epizyme Inc.'s (Nasdaq: EPZM) tazemetostat clinical trials sending the stock price plummeting $2.30 to close at $13.00. Related Stocks: Epizyme Inc Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Partial clinical hold on Epizyme's new enrollments By: MarketMinute.com Stock News April 24, 2018 at 18:02 PM EDT The Food and Drug Administration issued a partial clinical hold on new enrollments for Epizyme Inc.'s (Nasdaq: EPZM) tazemetostat clinical trials sending the stock price plummeting $2.30 to close at $13.00. Related Stocks: Epizyme Inc